Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The goal of this project is to evaluate the chronic effect (8 weeks) of RASILEZ 300mg
(aliskiren) on renal tissue oxygenation in patients with stage 1-2 hypertension, and to
compare the chronic effect (8 weeks) of RASILEZ 300mg (aliskiren) on renal tissue oxygenation
in patients with stage 1-2 hypertension with these effects with those of ESIDREX 25mg
(hydrochlorothiazide).